Uso de pruebas de diagnóstico rápido por detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19: orientaciones provisionales, 9 de marzo de 2022: anexo C de la web: estudio multipaís de valores y preferencias en la COVID-19 con las PDR-Ag del SARS-CoV-2
Ginebra; Organización Mundial de la Salud; 2022. (WHO/2019-nCoV/Ag-RDTs/Self_testing/Web_annex_C/2022.1).
in Spanish
| WHO IRIS
| ID: who-352909
Responsible library:
CH1.1
Full text:
Available
Collection:
Databases of international organizations
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 8: Outbreaks, emergencies and disasters
Database:
WHO IRIS
Main subject:
Reagent Kits, Diagnostic
/
Disease Outbreaks
/
Sensitivity and Specificity
/
Guidelines as Topic
/
Diagnostic Tests, Routine
/
Betacoronavirus
/
Self-Testing
/
COVID-19 Testing
/
COVID-19
Type of study:
Diagnostic study
/
Practice guideline
Aspects:
Patient-preference
Language:
Spanish
Year:
2022